News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Board of Directors Approves Quarterly Dividend
02/08/2022

DUBLIN, Ohio, Feb. 8, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record at the close of business on April 1, 2022.

About Cardinal Health 
Cardinal Health (NYSE: CAH) is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and (614) 757-8231

Investors: Kevin Moran, kevin.moran@cardinalhealth.com and (614) 757-7942

SOURCE Cardinal Health

More Company News
09/27/2022

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company...

09/08/2022

--Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- DUBLIN, Ohio, Sept. 8, 2022...

09/06/2022

Adds Four New Independent Directors to the Board Forms New Business Review Committee to Evaluate Portfolio and Operations DUBLIN, Ohio, Sept. 6, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

08/11/2022

Revenue increased 11% to $47.1 billion in the fourth quarter GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter Non-GAAP operating...

View all company news »